Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients

Franziska Schmelter, Franziska Schmelter, Bandik Föh, Bandik Föh, Alvaro Mallagaray, Johann Rahmöller, Johann Rahmöller, Marc Ehlers, Selina Lehrian, Vera von Kopylow, Inga Künsting, Anne Sophie Lixenfeld, Emily Martin, Mohab Ragab, Roza Meyer-Saraei, Roza Meyer-Saraei, Fabian Kreutzmann, Fabian Kreutzmann, Ingo Eitel, Ingo Eitel, Stefan Taube, Nadja Käding, Eckard Jantzen, Tobias Graf, Tobias Graf, Christian Sina, Christian Sina, Ulrich L. Günther

Open source

DOI
10.3389/fmolb.2021.737039
Published
12
Container
Frontiers in Molecular Biosciences
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmolb.2021.737039,
  title = {Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients},
  author = {Franziska Schmelter and Franziska Schmelter and Bandik Föh and Bandik Föh and Alvaro Mallagaray and Johann Rahmöller and Johann Rahmöller and Marc Ehlers and Selina Lehrian and Vera von Kopylow and Inga Künsting and Anne Sophie Lixenfeld and Emily Martin and Mohab Ragab and Roza Meyer-Saraei and Roza Meyer-Saraei and Fabian Kreutzmann and Fabian Kreutzmann and Ingo Eitel and Ingo Eitel and Stefan Taube and Nadja Käding and Eckard Jantzen and Tobias Graf and Tobias Graf and Christian Sina and Christian Sina and Ulrich L. Günther},
  year = {2021},
  journal = {Frontiers in Molecular Biosciences},
  doi = {10.3389/fmolb.2021.737039},
  url = {https://doi.org/10.3389/fmolb.2021.737039}
}

RIS

TY  - JOUR
TI  - Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients
AU  - Franziska Schmelter
AU  - Franziska Schmelter
AU  - Bandik Föh
AU  - Bandik Föh
AU  - Alvaro Mallagaray
AU  - Johann Rahmöller
AU  - Johann Rahmöller
AU  - Marc Ehlers
AU  - Selina Lehrian
AU  - Vera von Kopylow
AU  - Inga Künsting
AU  - Anne Sophie Lixenfeld
AU  - Emily Martin
AU  - Mohab Ragab
AU  - Roza Meyer-Saraei
AU  - Roza Meyer-Saraei
AU  - Fabian Kreutzmann
AU  - Fabian Kreutzmann
AU  - Ingo Eitel
AU  - Ingo Eitel
AU  - Stefan Taube
AU  - Nadja Käding
AU  - Eckard Jantzen
AU  - Tobias Graf
AU  - Tobias Graf
AU  - Christian Sina
AU  - Christian Sina
AU  - Ulrich L. Günther
PY  - 2021
JO  - Frontiers in Molecular Biosciences
DO  - 10.3389/fmolb.2021.737039
UR  - https://doi.org/10.3389/fmolb.2021.737039
ER  - 

APA

Schmelter, F., Schmelter, F., Föh, B., Föh, B., Mallagaray, A., Rahmöller, J., Rahmöller, J., Ehlers, M., Lehrian, S., Kopylow, V. V., Künsting, I., Lixenfeld, A. S., Martin, E., Ragab, M., Meyer-Saraei, R., Meyer-Saraei, R., Kreutzmann, F., Kreutzmann, F., Eitel, I., Eitel, I., Taube, S., Käding, N., Jantzen, E., Graf, T., Graf, T., Sina, C., Sina, C., & Günther, U. L. (2021). Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients. Frontiers in Molecular Biosciences. https://doi.org/10.3389/fmolb.2021.737039

Source records